QDEL — Quidelortho Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual income statement for Quidelortho, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2023 December 31st	2023 January 1st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	535	1,662	1,699	2,998	3,266
Cost of Revenue
Gross Profit	321	1,349	1,271	1,494	1,936
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	443	612	792	2,859	2,446
Operating Profit	92	1,050	906	139	820
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	77.2	1,040	900	-29.1	736
Provision for Income Taxes
Net Income After Taxes	72.9	810	704	-10.1	549
Net Income Before Extraordinary Items
Net Income	72.9	810	704	-10.1	549
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	74.8	811	704	-10.1	549
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.01	18.9	16.6	0.952	11.6